Utilization of Genomic Signatures to Identify Phenotype-Specific Drugs

Seiichi Mori, Jeffrey T. Chang, Eran R. Andrechek et al. · 2009

Read Utilization of Genomic Signatures to Identify Phenotype-Specific Drugs by Seiichi Mori, Jeffrey T. Chang, Eran R. Andrechek et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006772.txt.

Description

Seiichi Mori and colleagues used gene patterns to hunt for drugs matched to cancer types in PLOS ONE in 2009. Human cancers are complex and highly varied. Few treatments can match that complexity. The authors describe an approach built on genomic signatures. A signature is a pattern of gene activity marking a state.

Their method links signatures to drugs that fit specific phenotypes. A phenotype is the observable character of a tumor. Matching drugs to phenotypes expands discovery opportunities. It may find new uses for existing compounds. The approach offers a systematic shortcut through cancer's variety, pairing each tumor pattern with candidate treatments.

Catalog record

CREATORSeiichi Mori, Jeffrey T. Chang, Eran R. Andrechek et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006772

Browse the full library · About the Tower of Babel